There’s a wealth of information in every sample
In life science research, speed to discovery is dependent on applying biomarker measurements in the preclinical stage.
It’s clear that having access to a large biorepository of samples and their associated clinical data would accelerate life-changing medicines and treatments.
But these samples are often discarded.
It’s too challenging for diagnostics labs to share data
You know your remnant samples carry value, but life science researchers are not contacting directly with your lab to get the information they need to answer questions at scale.
Too many logistical, regulatory and business obstacles stand in the way
Legal Framework for gaining consent
Informatics infrastructure to collect store and safely share data
Resources to develop life science opportunities
Resources and effort required to stand up biobanking operations and characterize samples
Amount of data required to serve projects
The Ovation Research Network is here to change that.
We’re bringing together remnant samples and data from independent diagnostic labs to create one of the world’s most comprehensive and diverse clinicogenomic databases.
Your lab will finally gain the infrastructure and scale you need to mobilize the value of your remnant samples for an extensive variety of research projects—while generating additional revenue.
Mobilize your remnant samples to accelerate therapeutic and diagnostic R&D
More than a LIMS software company. More than a specimen procurement company. We’re your partners in growing your laboratory business. And we’re invested in your success.
Be at the forefront of new treatments and medicines
Generate additional revenue for your lab
Accelerate internal research & development
Your lab will have the opportunity to access aggregated and de-identified clinicogenomic data for internal assay development and validation.
How it works
A sample enters your lab for testing as it does today. The only change is that the patient will be notified that their de-identified sample and associated data will be used in research.
Ovation ensures that shipping your remnant samples to our biorepository is as seamless as possible and results in zero cost to your lab.
Ovation uses advanced technology to de-identify samples before they’re stored in our biorepository for future processing. De-identified patient information will also be stored in our database.
A healthcare or life science industry researcher approaches Ovation for clinicogenomic data to help with biomarker discovery or assay validation studies.
Your Lab Receives Additional Revenue
Ovation provides industry researchers existing data or searches our biorepository for de-identified samples that match the desired cohort. We’ll send these samples back to Research Network labs to perform additional testing for the required measurements. Your lab receives direct payment for performing research testing or for the use of your remnant samples.
Leave it to the experts
Our team of clinical affairs specialists will work with you every step of the way to ensure your participation is easy and fits into your routine operations.
Consenting strategy for research testing
We’ll help your lab adopt a universal consenting strategy developed by legal experts specializing in patient data privacy and reviewed by external IRBs.
Privacy and de- identification
We’ll take responsibility for the de-identification of all samples and data in accordance with the requirements set forth in 45 CFR 164.514(b)(1).
Storage & shipping guidance
Your team will be trained in best practices to ensure high sample quality through storage, documentation, and shipping steps.
Is there a cost to join the Ovation Research Network?
We want to keep our samples in our on-site biobanking facility. Can we still participate in the network?
Yes, we understand that you can’t always move your specimens to an off-site biorepository. In that case, your lab will index the specimens in our software and continue to store them on site. Once we request a specimen for a research project, your lab will determine which of these indexed specimens have sufficient material for research use as part of the verification process. You’ll then send those verified specimens to Ovation’s biorepository, or—if your lab has the capabilities—peform research testing on these specimens.
What types of samples is the network interested in collecting?
We’re interested in most types of samples that your lab collects that contain enough human DNA or RNA to get value from. The model is to cast a wide net and capture samples from a broad patient population across different therapeutic areas.
Are you providing remnant samples directly to healthcare and life science industry researchers?
No, remnant samples will never be directly provided to health industry researchers. We take the de-identified genomic data from remnant samples, additional de-identified data derived from research testing of those samples, securely link it with de-identified clinical data, and place it into our clinicogenomic database. Health industry researchers are only provided data from that database.
Do I need to use Ovation’s LIMS to participate in the network?
You do not need to use Ovation LIMS to participate in the Ovation Research Network. We do have software that we’ll help you get in place to serve as the informatics infrastructure for the collection, cataloging, and shipment of the samples, but it’s okay if your LIMS is separate from Ovation.
Of course, things are a bit less complicated if you’re using Ovation as your LIMS provider as well, so we encourage using it for your molecular testing. Still, we understand this is not always possible and would love for your lab to participate in ORN anyways.”
Are all labs in the network eligible for the sponsored research-related testing?
What types of research testing opportunities are available to diagnostic labs in the network?
We’re always looking to characterize these samples as fully as possible when we pull them out of the biorepository, which is why we’re typically performing a wide range of testing, including:
- Total nucleic acid extraction from those samples (collecting both DNA and RNA from those libraries)
- Whole-genome sequencing
- RNA (Whole-exome) sequencing
- Determining disease vs. normal tissue within the sample
As you can see from the above, almost any lab can perform at least some of the research testing we’re doing in the network.
How will Ovation ensure proper de-identification of samples and data?
Ovation will ensure that patient samples and information are de-identified in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule before they’re entered into Ovation’s database. Internationally recognized experts on health data privacy have assessed Ovation’s database (design and structure), policies, and data processing routines and determined that they meet the de-identification requirements, satisfying the “Expert Determination” method outlined in the HIPAA Privacy Rule (45 CFR 164.514(b)(1)).
How is Ovation different from a specimen procurement company?
Unlike specimen procurement companies, Ovation is bringing diagnostic labs into the real-world data business. We’re not selling specimens directly to health industry and life science researchers. Instead, we’re creating a clinicogenomic database that aims to fundamentally change the way that preclinical research is done today. This includes giving diagnostic labs the opportunity to participate by performing paid research testing and accessing aggregated data for their internal assay development and validation. In other words, this is not a transactional relationship. It’s a long-term partnership.
Ready to unlock the value of your remnant samples and increase the ability of researchers to bring life-saving therapies to market?
If you’re currently discarding samples, we’d love to talk.